Immunocompromised patients
Showing 1 - 25 of 804
Intradermal Covid-19 Vaccine, Immungenicity and Safety, Immunocompromised Patients Trial in Hong Kong (ID BNT162b2 vaccine, IM
Recruiting
- Intradermal Covid-19 Vaccine
- +3 more
- ID BNT162b2 vaccine
- IM BNT162b2 vaccine
-
Hong Kong, Hong KongQueen Mary Hospital
Feb 19, 2023
Covid-19 Convalescent Plasma and Monoclonal Antibodies Treatment
Recruiting
- COVID-19 Convalescent Plasma Treatment
-
Strasbourg, FranceService des Maladies Infectieuses et Tropicales - CHU de Strasbo
Jun 15, 2023
Azole Resistance Inducing Mutations on DNA Extracted Directly
Recruiting
- Invasive Aspergillosis
- Aspergillus PCR
-
Rotterdam, Zuid Holland, NetherlandsErasmus Medical Center (EMC)
Oct 5, 2023
HIV Seropositivity, Immunodeficiency, Vaccination Reaction Trial in Ghent (Blood draw)
Recruiting
- HIV Seropositivity
- +3 more
- Blood draw
-
Ghent, East Flanders, BelgiumUH Ghent
Jan 4, 2023
Severe Acute Respiratory Infection, Community-acquired Pneumonia, Respiratory Tract Infections Trial in Jinan (mNGS-guided
Recruiting
- Severe Acute Respiratory Infection
- +4 more
- mNGS-guided treatment
-
Jinan, Shandong, ChinaQilu Hospital of Shandong university
Jan 28, 2023
ICU-acquired Colonization and Infection Related to MDR in
Completed
- Immunocompromised Host
- Critical Care
-
Amiens, France
- +6 more
Oct 4, 2022
De-escalation - Antifungal Treatment Immunocompromised Patients
Recruiting
- Invasive Fungal Disease
- Critical Illness
-
Lille, FranceCHU Lille
Oct 14, 2022
Cytomegalovirus Reactivation in Non Immunocompromised Patients
Completed
- Cardiac Surgery
- Blood test
-
Beer Sheva, IsraelSoroka University Medical Center
Oct 24, 2022
Immunocompromised Patients Trial in Switzerland (Moderna COVID-19 Vaccine, mRNA-1273 (100 µg), Pfizer-BioNTech COVID-19 Vaccine
Active, not recruiting
- Immunocompromised Patients
- Moderna COVID-19 Vaccine, mRNA-1273 (100 μg)
- Pfizer-BioNTech COVID-19 Vaccine BNT162b2 (30 µg)( Comirnaty®)
-
Basel, Switzerland
- +3 more
Oct 18, 2022
Immunodeficiency, Immunosuppression, HIV Trial in La Jolla (Access to Cue Health COVID-19 Remote testing and treatment for
Recruiting
- Immunodeficiency
- +8 more
- Access to Cue Health COVID-19 Remote testing and treatment for COVID-19
-
La Jolla, CaliforniaScripps Research
Dec 22, 2022
SARS CoV 2 Infection, COVID-19 Trial in Brussels (Humoral immunity)
Enrolling by invitation
- SARS CoV 2 Infection
- COVID-19
- Humoral immunity
-
Brussels, BelgiumSciensano
Jan 16, 2023
PCP in Immunocompromised Population in Southern China
Recruiting
- Immunocompromised Patients
- +3 more
- PCR was used to detect pneumocystis in respiratory specimens
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Nov 3, 2022
COVID-19, Immunodeficiency Trial (Paxlovid 5 days, Paxlovid 10 days, Tixagevimab and Cilgavimab)
Not yet recruiting
- COVID-19
- Immunodeficiency
- Paxlovid 5 days
- +2 more
- (no location specified)
Oct 18, 2022
HIV, Organ Transplantation, Lymphoma, Non-Hodgkin Trial in Melbourne (Pfizer Bivalent COVID-19 Vaccine, Moderna Bivalent mRNA
Recruiting
- HIV
- +5 more
- Pfizer Bivalent COVID-19 Vaccine
- Moderna Bivalent mRNA vaccine
-
Melbourne, Victoria, AustraliaAlfred Health
Jan 31, 2023
Pneumocystis Jirovecii Pneumonia in Non-HIV-infected
Active, not recruiting
- Pneumocystis Jirovecii Infection
-
Vandoeuvre Les Nancy, Lorraine, FranceUniversité de Lorraine, CHRU Nancy and APEMAC
Jul 12, 2022
SARS-CoV-2 Infection Trial in Washington (Coronavirus-specific T cell (CST))
Recruiting
- SARS-CoV-2 Infection
- Coronavirus-specific T cell (CST)
-
Washington, District of Columbia
- +1 more
Sep 1, 2022
Pneumonia, Ventilator-Associated, Pneumonia, Hospital-Acquired, Immunodeficiency Trial (PCR based strategy, Standard care)
Not yet recruiting
- Pneumonia, Ventilator-Associated
- +2 more
- PCR based strategy
- Standard care
- (no location specified)
Dec 13, 2022
Rheumatoid Arthritis, Autoimmune Rheumatologic Disease, Systemic Lupus Erythematosus Trial in Québec (COVID-19 vaccine)
Recruiting
- Rheumatoid Arthritis
- +8 more
- COVID-19 vaccine
-
Montréal, Quebec, Canada
- +1 more
Jan 13, 2023
Chikungunya Virus Infection Trial (VLA1553)
Not yet recruiting
- Chikungunya Virus Infection
- VLA1553
- (no location specified)
Aug 31, 2023
COVID-19 Vaccines in Immunocompromised and Healthy Individuals
Recruiting
- Covid19
- Immunosuppression
- Blood sample
- Saliva sample
-
Graz, AustriaMedical University of Graz
May 9, 2022
Influenza in People With Normal and Weakened Immune Systems
Recruiting
- Viral Infections
- Respiratory Infections
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022
Compare mRNA-1273 Versus BNT162b2 COVID-19 Vaccines Among
Completed
- SARS-CoV-2
-
New York, New YorkAetion Inc.
May 5, 2022